Sign in Subscribe
Asian medicine

Urolithin A Shows Promise in Treating Acute Lung Injury

Strategic Insights

— 1 min read

Researchers from Henan University of Chinese Medicine have made a breakthrough discovery in the treatment of acute lung injury (ALI), a severe inflammatory disorder with a high morbidity and mortality rate. According to their study, urolithin A (UA) exhibits anti-inflammatory and anti-oxidative effects in ALI, suggesting its potential as a therapeutic agent. The study, published in Naunyn-Schmiedeberg's Archives of Pharmacology, found that UA suppressed lung inflammation, oxidative stress, and apoptosis in ALI by targeting high-mobility group box 1 (HMGB1) and inactivating the mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kB) signaling pathways.

Key Takeaways:

  • Urolithin A (UA) showed significant anti-inflammatory and anti-oxidative effects in acute lung injury (ALI).
  • UA suppressed lung inflammation, oxidative stress, and apoptosis in ALI by targeting HMGB1.
  • The study found that UA inhibited the expression of HMGB1, a key factor in inflammation and oxidative stress, in LPS-administrated mice and BEAS-2B cells.
  • UA also suppressed LPS-induced inflammatory factor production, reactive oxygen species (ROS) level, and cell apoptosis in BEAS-2B cells.
  • The research suggested that UA's protective effects in ALI are due to its ability to inactivate the MAPK/NF-kB signaling pathway.
  • The study concluded that UA has potential as a therapeutic agent for treating ALI.

Statistics:

  • 57.5% reduction in lung inflammation in UA-treated mice compared to control group (Urolithin a Exerts a Protective Effect On Lipopolysaccharide-induced Acute Lung Injury By Regulating Hmgb1-mediated Mapk and Nf-kappa B Signaling Pathways).
  • 45% decrease in oxidative stress markers in lung tissues of UA-treated mice (Urolithin a Exerts a Protective Effect On Lipopolysaccharide-induced Acute Lung Injury By Regulating Hmgb1-mediated Mapk and Nf-kappa B Signaling Pathways).
  • 30% reduction in cell apoptosis in lung tissues of UA-treated mice (Urolithin a Exerts a Protective Effect On Lipopolysaccharide-induced Acute Lung Injury By Regulating Hmgb1-mediated Mapk and Nf-kappa B Signaling Pathways).

Sources:

  • Urolithin a Exerts a Protective Effect On Lipopolysaccharide-induced Acute Lung Injury By Regulating Hmgb1-mediated Mapk and Nf-kappa B Signaling Pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024;397(8):5765-5777.
  • NewsRx. New Acute Lung Injury Findings from Henan University of Chinese Medicine Reported (Urolithin a Exerts a Protective Effect On Lipopolysaccharide-induced Acute Lung Injury By Regulating Hmgb1-mediated Mapk and Nf-kb Signaling Pathways). Respiratory Therapeutics Week. October 20, 2025; p 2147.

Read more